IDDI in the Media.
Read the articles related to our know-how and expertise in clinical research and how we optimize the design and conduct of clinical trials.
Finding the one: How to choose a Clinical Partner in Sea of Service Providers
What should companies look for when selecting a CRO clinicalpartner? Just one in ten drug candidates are successful in clinical trials, and the number of products making it from development to approval is currently at an all-time low.It means sponsors […]
Integration of Biomarker Validation in Clinical Development in Oncology
The development and qualification of biomarkers are keys to the future of drug development and precision medicine, particularly in oncology. Read IDDI Article published in Applied Clinical Trials. Precision medicine relies on validated biomarkers that allow classification of patients by […]
IDDI in Contract Pharma
Insight on the pharma and biopharma trends impacting CROs, Outsourcing in today’s market, and advances in clinical research. READ IDDI ARTICLE PUBLISHED IN CONTRACT PHARMA ! Kristin Brooks, Contract Pharma 04.27.20 Serge Bodart of IDDI provides insight on the pharma […]
Surrogate endpoints create potential, require statistical validation
Transforming statistical data into a surrogate endpoint can enable comprehension of trial results sooner than usual, but few make the cut after formal validation, says drug development expert and DIA panelist. READ ARTICLE HERE Interview of Dr. Marc Buyse, ScD, […]
Using disease free survival as a primary endpoint in early breast cancer
IDDI in collaboration with Roche have identified why using disease-free survival as a primary endpoint in early breast cancer is the way forward IDDI’s findings suggest that it is appropriate to use disease-free survival (DFS) as a surrogate for overall […]